CM
THC icon

Castleark Management’s Tenet Healthcare THC Stock Holding History

Castleark Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48,870
Closed -$8.12M – 329
2024
Q3 		$8.12M Sell
48,870
-9,220
-16% -$1.39M 0.33% 61
2024
Q2 		$7.73M Buy
58,090
+36,770
+172% +$4.43M 0.32% 62
2024
Q1 		$2.24M Sell
21,320
-2,780
-12% -$250K 0.09% 173
2023
Q4 		$1.82M Sell
24,100
-52,280
-68% -$3.31M 0.08% 179
2023
Q3 		$5.03M Sell
76,380
-840
-1% -$62.8K 0.26% 90
2023
Q2 		$6.28M Buy
+77,220
New +$5.5M 0.28% 75
2022
Q4 		– Sell
-36,570
Closed -$1.89M – 320
2022
Q3 		$1.89M Sell
36,570
-36,110
-50% -$2.14M 0.11% 157
2022
Q2 		$3.82M Buy
72,680
+57,965
+394% +$4.03M 0.2% 115
2022
Q1 		$1.26M Sell
14,715
-52,750
-78% -$4.33M 0.05% 205
2021
Q4 		$5.51M Sell
67,465
-48,005
-42% -$3.51M 0.2% 120
2021
Q3 		$7.67M Sell
115,470
-75,800
-40% -$5.38M 0.29% 92
2021
Q2 		$12.8M Sell
191,270
-11,320
-6% -$702K 0.43% 55
2021
Q1 		$10.5M Buy
+202,590
New +$10.2M 0.38% 80
2018
Q3 		– Sell
-265,050
Closed -$8.9M – 411
2018
Q2 		$8.9M Buy
+265,050
New +$8.24M 0.27% 121

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Castleark Management's THC Position: Q4 2024 in Review

Castleark Management sold out of Tenet Healthcare (THC) in Q4 2024, closing a stake of 48,870 shares — an estimated $8.12M sold.

Castleark Management first reported a position in THC in Q2 2018 and held it in 14 quarters. The position peaked at $12.8M in Q2 2021. 578 funds tracked by Wall St. Rank hold THC as of Q4 2024.

  • Castleark Management reported no remaining Tenet Healthcare position as of Q4 2024 after selling out during the quarter.
  • Castleark Management sold 48,870 Tenet Healthcare shares in Q4 2024, an estimated $8.12M.
  • Castleark Management first reported a position in Tenet Healthcare in Q2 2018 and held it in 14 quarters.
  • Castleark Management's Tenet Healthcare position peaked at $12.8M in Q2 2021.
  • 578 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.

Based on Castleark Management's 13F filing for Q4 2024, filed 18 Feb 2025.